Altimmune Inc.

Altimmune Inc.

World Rank (Jan-05-2024)
11,224
Market Cap (Jan-05-2024)
0.628 Billion USD
World Rank (Jul-30-2023)
19,229
Market Cap (Jul-30-2023)
0.160 Billion USD
World Rank (Jan-07-2022)
15,840
Market Cap (Jan-07-2022)
0.339 Billion USD
Headquarters Country
USA
Market Cap (Mar-08-2026)
0.40
Headquarters City/State
Maryland
World Region
Americas
World Subregion
Northern America
Business Sector
Healthcare
Biotechnology
Company Website
ALTIMMUNE, INC.
Company Profile
Altimmune, Inc. is a clinical stage biopharmaceutical company focused on developing treatments for obesity and liver diseases and intranasal vaccines. The company annual revenue is 8.1 million USD and total assets are 245 million USD as on 2020. The headquarters is in USA.

Share